rs200001957

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_SupportingO8_SupportingB3_Supporting

The NM_006218.4(PIK3CA):c.470A>G (p.Asn157Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene PIK3CA is a known oncogene (CancerMine: 3 TSG, 156 oncogene, 103 driver citations). The gene PIK3CA is a cancer driver gene (CancerMine: 3 TSG, 156 oncogene, 103 driver citations). The variant allele was found at a cumulative frequency of 0.000018 (AC=29) in the gnomAD database across 1,612,774 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000013. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.N157D: Uncertain_significance (ClinVar VariationId 4861898, 1 star)

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

PIK3CA
NM_006218.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.86

Publications

1 publications found
Variant links:
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia
  • megalencephaly-capillary malformation-polymicrogyria syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • vascular malformation
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006218.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000013 — very rare (O3 supporting [+1])
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 6.15 (threshold ≥3.09 for constraint)
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_006218.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

PIK3CA NM_006218.4
MANE Select
HGVSc / HGVSpc.470A>Gp.Asn157Ser
Exon rankExon 3 of 21
missense
Prot: NP_006209.2UniProt: P42336

Ensembl Transcripts

PIK3CA ENST00000263967.4
TSL:2MANE Select
HGVSc / HGVSpc.470A>Gp.Asn157Ser
Exon rankExon 3 of 21
missense
Prot: ENSP00000263967.3UniProt: P42336
PIK3CA ENST00000955190.1
HGVSc / HGVSpc.470A>Gp.Asn157Ser
Exon rankExon 3 of 21
missense
Prot: ENSP00000625249.1UniProt: A0ACI8UU87
PIK3CA ENST00000876545.1
HGVSc / HGVSpc.470A>Gp.Asn157Ser
Exon rankExon 4 of 22
missense
Prot: ENSP00000546604.1UniProt: P42336

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000263
AC:4
Hom:0
AN:152172
Cov:32
GnomAD2 exomes
AF: 0.0000120
AC:3
AN:249476
GnomAD4 exome
AF: 0.0000171
AC:25
Hom:0
AN:1460602
Cov:30
GnomAD4 genome
AF: 0.0000263
AC:4
Hom:0
AN:152172
Cov:32
TOPMed (Bravo)
AF: 0.0000340
AC:9
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:16840
Local & regional cohorts 2 sources
ChinaMAP Phase 1
AF: 0.000246
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.000223
AC:2
Hom:0
AN:8960
Showing 8 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.00 028414 0.0000347 128830
Epi25
(Epilepsy)
0.0000715 341952 0.0000150 166882
SCHEMA
(Schizophrenia)
0.0000530 6113110 0.0000210 4190590
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Cowden syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic20
AlphaMissense
Benign0.062
BayesDel_addAF
Benign-0.28T
BayesDel_noAF
Benign-0.47
CADD
Benign18
DANN
Benign0.81
DEOGEN2
Benign0.24T
Eigen
Benign-0.15
Eigen_PC
Benign0.083
FATHMM_MKL
Benign0.63D
FuncVEP CTI
Benign0.0039
GPN-Star LLR
N/A-6.7
GPN-Star score
N/A6.7
LIST_S2
Uncertain0.90D
M_CAP
Benign0.0068T
MetaRNN
Benign0.12T
MetaSVM
Benign-0.85T
Mutation Taster
N/A88/12polymorphism
MutationAssessor
Benign0.14N
PhyloP100
Benign2.9
popEVE
Benign-3.5
PrimateAI
Benign0.42T
PROVEAN
Benign-0.11N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Benign0.093
Sift
Benign0.74T
Sift4G
Benign0.73T
Varity_R
N/A0.10
VESM-3B
Benign-3.2
Showing 30 of 30 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.